Welcome to Lipidor AB

Lipidor AB was established in 2009 to capitalize on the founders’ extensive experience in working with lipids and product development.

Lipidor’s activities focus on examining how lipids can be used in combination with substances and materials not traditionally associated with them. Lipidor has developed the AKVANO™ technology, a novel dosage form for topical delivery of drugs and cosmetics.

The company seeks to patent the founders’ inventions to commercially develop them in collaboration with interested parties.

R&D is conducted at Karolinska Institute and Stockholm University.

In July 2009, Karolinska Development AB invested in Lipidor and shares the company ownership with the founders.